Genscript Biotech Corporation, a leading name in the research and development services sector, is headquartered in China (CN) and operates globally, with significant presence in North America and Europe. Founded in 2002, Genscript has established itself as a pioneer in providing innovative solutions in gene synthesis, peptide synthesis, and antibody development, catering to the needs of the biotechnology and pharmaceutical industries.
The company’s core offerings, including custom DNA and protein services, are distinguished by their high quality and rapid turnaround times, making them invaluable to researchers and developers. Genscript's commitment to advancing scientific discovery has earned it a prominent market position, recognised for its contributions to genomics and proteomics. With numerous accolades and a robust portfolio, Genscript continues to drive innovation in the life sciences sector.
+25 vs industry average
Genscript Biotech Corporation’s score of 55 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Genscript Biotech Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services is among the most carbon-intensive industries
Industry performance
The Research Services industry has reduced its overall emissions by 19% since 2018
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Genscript Biotech Corporation's reported carbon emissions
GenScript Biotech Corporation: Carbon Emissions and Climate Commitments
GenScript Biotech Corporation, a research and development services company headquartered in China, has outlined significant climate commitments aligned with the Science Based Targets initiative (SBTi).
Greenhouse Gas Emissions Data
2024:
- Scope 1 emissions: Approximately 39,376,800 kg CO2e.
- Scope 2 emissions (market-based): Approximately 114,034,820 kg CO2e.
- Scope 3 emissions: Approximately 387,589,810 kg CO2e.
- Total reported emissions (Scope 1 + Scope 2 + Scope 3): Approximately 540,901,730 kg CO2e.
2023:
- Scope 1 emissions: Approximately 48,821,780 kg CO2e.
- Scope 2 emissions (market-based): Approximately 83,758,360 kg CO2e.
- Scope 3 emissions: Approximately 314,658,760 kg CO2e.
- Total reported emissions (Scope 1 + Scope 2 + Scope 3): Approximately 447,238,900 kg CO2e.
Previous reporting years (2017 and 2018) also detail Scope 1 and Scope 2 emissions, showing a significant increase in reported Scope 1 and Scope 2 emissions between 2018 and 2023, and a substantial increase in Scope 3 emissions.
Climate Commitments and Targets
GenScript Biotech Corporation has committed to ambitious climate goals:
- Net-Zero by 2050: The company aims to achieve net-zero greenhouse gas emissions across its entire value chain by the year 2050.
- Near-Term Targets (by 2033 from a 2023 base year):
- A reduction of absolute Scope 1 and 2 greenhouse gas emissions by 54.6%.
- A reduction of absolute Scope 3 greenhouse gas emissions from fuel and energy-related activities and waste generated in operations by 32.5%.
- Supplier Engagement: By 2029, GenScript Biotech Corporation aims for 83% of its suppliers (covering purchased goods and services, capital goods, and upstream transportation and distribution) to have their own science-based targets.
- Long-Term Targets (by 2050 from a 2023 base year):
- A reduction of absolute Scope 1 and 2 greenhouse gas emissions by 90%.
- A reduction of absolute Scope 3 greenhouse gas emissions by 90%.
These targets, validated by the SBTi, demonstrate GenScript's commitment to aligning its operations and value chain with climate science to limit global warming to 1.5°C.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Genscript Biotech Corporation’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Genscript Biotech Corporation
Frequently asked questions
Common questions about Genscript Biotech Corporation’s sustainability data and climate commitments
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project